T. Rowe Price Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319M | Sell |
|
|||||
|
2025
Q1 | $635M | Sell |
|
|||||
|
2024
Q4 | $689M | Sell |
|
|||||
|
2024
Q3 | $1.46B | Buy |
|
|||||
|
2024
Q2 | $1.41B | Buy |
|
|||||
|
2024
Q1 | $892M | Sell |
|
|||||
|
2023
Q4 | $1.89B | Buy |
|
|||||
|
2023
Q3 | $1.7B | Buy |
|
|||||
|
2023
Q2 | $1.07B | Buy |
|
|||||
|
2023
Q1 | $924M | Buy |
|
|||||
|
2022
Q4 | $775M | Buy |
|
|||||
|
2022
Q3 | $258M | Sell |
|
|||||
|
2022
Q2 | $456M | Sell |
|
|||||
|
2022
Q1 | $644M | Sell |
|
|||||
|
2021
Q4 | $600M | Buy |
|
|||||
|
2021
Q3 | $557M | Sell |
|
|||||
|
2021
Q2 | $663M | Sell |
|
|||||
|
2021
Q1 | $711M | Sell |
|
|||||
|
2020
Q4 | $704M | Sell |
|
|||||
|
2020
Q3 | $911M | Buy |
|
|||||
|
2020
Q2 | $841M | Sell |
|
|||||
|
2020
Q1 | $899M | Buy |
|
|||||
|
2019
Q4 | $947M | Buy |
|
|||||
|
2019
Q3 | $757M | Buy |
|
|||||
|
2019
Q2 | $512M | Buy |
|
|||||
|
2019
Q1 | $483M | Buy |
|
|||||
|
2018
Q4 | $465M | Buy |
|
|||||
|
2018
Q3 | $469M | Sell |
|
|||||
|
2018
Q2 | $476M | Sell |
|
|||||
|
2018
Q1 | $449M | Sell |
|
|||||
|
2017
Q4 | $467M | Sell |
|
|||||
|
2017
Q3 | $521M | Sell |
|
|||||
|
2017
Q2 | $514M | Sell |
|
|||||
|
2017
Q1 | $535M | Sell |
|
|||||
|
2016
Q4 | $506M | Buy |
|
|||||
|
2016
Q3 | $497M | Buy |
|
|||||
|
2016
Q2 | $414M | Sell |
|
|||||
|
2016
Q1 | $423M | Sell |
|
|||||
|
2015
Q4 | $510M | Sell |
|
|||||
|
2015
Q3 | $445M | Sell |
|
|||||
|
2015
Q2 | $669M | Sell |
|
|||||
|
2015
Q1 | $713M | Sell |
|
|||||
|
2014
Q4 | $736M | Sell |
|
|||||
|
2014
Q3 | $674M | Sell |
|
|||||
|
2014
Q2 | $591M | Sell |
|
|||||
|
2014
Q1 | $623M | Buy |
|
|||||
|
2013
Q4 | $572M | Sell |
|
|||||
|
2013
Q3 | $804M | Buy |
|
|||||
|
2013
Q2 | $631M | Buy |
|